EIT Health-supported start-up, Arthex Biotech, has successfully closed a €42 million Series B financing round. Prior to attracting these funds, the Valencia-based clinical-stage biotech start-up received an EIC accelerator grant, having been fast-tracked through our support.
/PRNewswire/ ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs.
/PRNewswire/ Arthex Biotech S.A., a pre-clinical-stage biotechnology company pioneering innovative microRNA modulating approaches to diseases with high.
/PRNewswire/ Arthex Biotech S.A., a pre-clinical stage biotechnology company pioneering innovative microRNA modulating approaches to diseases with high.